MTOR and systemic lupus erythematosus: Upstream factors that drive increased mTOR activity in SLE are increased reactive oxygen intermediates (ROI) and nitric oxide, decreased levels of the reduced form of glutathione (GSH), and elevated mitochondrial potential.